5′-aminoimidazole-4-carboxyamide-ribonucleoside-activated glucose transport is not prevented by nitric oxide synthase inhibition in rat isolated skeletal muscle

Clinical and Experimental Pharmacology and Physiology

Volumn 31, Issue 7, 2004, Pages 419-423

  Stephens, T J ^a   Canny, B J ^a   Snow, R J ^b   McConell, G K ^a,c  

^a MONASH UNIVERSITY   (Australia)

^b DEAKIN UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

AMP activated protein kinase; Contraction; Exercise; Glucose transport; Nitric oxide synthase; Nitric oxide synthase inhibition; Skeletal muscle

Indexed keywords

3 METHYLGLUCOSE; 5' AMINOIMIDAZOLE 4 CARBOXYAMIDE RIBONUCLEOSIDE; 5' AMINOIMIDAZOLE 4 CARBOXYAMIDE RIBONUCLEOTIDE; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; N(G) METHYLARGININE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; RIBONUCLEOSIDE DERIVATIVE; RIBONUCLEOTIDE; UNCLASSIFIED DRUG; 5 AMINO 4 IMIDAZOLECARBOXAMIDE; AICA RIBONUCLEOTIDE; DRUG DERIVATIVE; ENZYME INHIBITOR;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; GLUCOSE TRANSPORT; HEXOSE TRANSPORT; IN VITRO STUDY; INCUBATION TIME; MALE; MUSCLE CONTRACTION; MUSCLE METABOLISM; NONHUMAN; RAT; SKELETAL MUSCLE; ACTIVE TRANSPORT; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

3-O-METHYLGLUCOSE; AMINOIMIDAZOLE CARBOXAMIDE; ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; ENZYME INHIBITORS; GLUCOSE; MALE; MUSCLE CONTRACTION; MUSCLE, SKELETAL; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; RATS; RATS, SPRAGUE-DAWLEY; RIBONUCLEOTIDES;

EID: 3843052559     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2004.04014.x     Document Type: Article

References (34)

1. Zisman A, Peroni OD, Abel ED et al. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat. Med. 2000; 6: 924-8.
2. Hayashi T, Wojtaszewski JF, Goodyear LJ. Exercise regulation of glucose transport in skeletal muscle. Am. J. Physiol. 1997; 273: E1039-51.
3. Richter EA, Derave W, Wojtaszewski JF. Glucose, exercise and insulin: Emerging concepts. J. Physiol. 2001; 535: 313-22.
4. Merrill GF, Kurth EJ, Hardie DG, Winder WW. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am. J. Physiol. 1997; 273: E1107-12.
5. Hayashi T, Hirshman MF, Kurth EJ, Winder WW, Goodyear LJ. Evidence for 5′-AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 1998; 47: 1369-73.
6. Bergeron R, Russell 3rd RR, Young LH et al. Effect of AMPK activation on muscle glucose metabolism in conscious rats. Am. J. Physiol. 1999; 276: E938-44.
7. Russell 3rd RR, Bergeron R, Shulman GI, Young LH. Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. Am. J. Physiol. 1999; 277: H643-9.
8. Kurth-Kraczek EJ, Hirshman MF, Goodyear LJ, Winder WW. 5′-AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 1999; 48: 1667-71.
9. Mu J, Brozinick Jr JT, Valladares O, Bucan M, Birnbaum MJ. A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mol. Cell 2001; 7: 1085-94.
10. Kapur S, Bedard S, Marcotte B, Cote CH, Marette A. Expression of nitric oxide synthase in skeletal muscle: A novel role for nitric oxide as a modulator of insulin action. Diabetes 1997; 46: 1691-700.
11. Higaki Y, Hirshman MF, Fujii N, Goodyear LJ. Nitric oxide increases glucose uptake through a mechanism that is distinct from the insulin and contraction pathways in rat skeletal muscle. Diabetes 2001; 50: 241-7.
12. Etgen Jr GJ, Fryburg DA, Gibbs EM. Nitric oxide stimulates skeletal muscle glucose transport through a calcium/contraction- and phosphatidylinositol-3-kinase-independent pathway. Diabetes 1997; 46; 1915-19.
13. Balon TW, Nadler JL. Evidence that nitric oxide increases glucose transport in skeletal muscle. J. Appl. Physiol. 1997; 82: 359-63.
14. Young ME, Radda GK, Leighton B. Nitric oxide stimulates glucose transport and metabolism in rat skeletal muscle in vitro. Biochem. J. 1997; 322: 223-8.
15. Fryer LG, Hajduch E, Rencurel F et al. Activation of glucose transport by AMP-activated protein kinase via stimulation of nitric oxide synthase. Diabetes 2000; 49: 1978-85.
16. Rottman J, Bracy D, Malabanan C, Yue Z, Clanton J, Wasserman D. Contrasting effects of exercise and NOS inhibition on tissue-specific fatty acid and glucose uptake in mice. Am. J. Physiol. Endocrinol. Metab. 2002; 283: E116-23.
17. Bradley SJ, Kingwell BA, McConell GK. Nitric oxide synthase inhibition reduces leg glucose uptake but not blood flow during dynamic exercise in humans. Diabetes 1999; 48: 1815-21.
18. Kingwell B, Formosa M, Muhlmann M, Bradley S, McConell G. Nitric oxide synthase inhibition reduces glucose uptake during exercise in individuals with type 2 diabetes more than in control subjects. Diabetes 2002; 51: 2572-80.
19. Roberts CK, Barnard RJ, Scheck SH, Balon TW. Exercise-stimulated glucose transport in skeletal muscle is nitric oxide dependent. Am. J. Physiol. 1997; 273: E220-5.
20. Chen ZP, McConell GK, Michell BJ, Snow RJ, Canny BJ, Kemp BE. AMPK signaling in contracting human skeletal muscle. Acetyl-CoA carboxylase and NO synthase phosphorylation. Am. J. Physiol. Endocrinol. Metab. 2000; 279: E1202-6.
21. Chen Z-P, Stephens TJ, Murthy S et al. Effect of exercise intensity on skeletal muscle AMPK signaling in humans. Diabetes 2003; 52: 2205-12.
22. Stephens TJ, Chen Z-P, Canny BJ, Michell BJ, Kemp BE, McConell GK. Progressive increase in human skeletal muscle AMPKalpha2 activity and ACC phosphorylation during exercise. Am. J. Physiol. Endocrinol. Metab. 2002; 282: E688-94.
23. Balon TW, Nadler JL. Nitric oxide release is present from incubated skeletal muscle preparations. J. Appl. Physiol. 1994; 77: 2519-21.
24. Corton JM, Gillespie JG, Hawley SA, Hardie DG. 5-Aminoimidazole-4- carboxamideribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur. J. Biochem. 1995; 229: 558-65.
25. Kemp BE, Mitchelhill KI, Stapleton D, Michell BJ, Chen ZP, Witters LA. Dealing with energy demand: The AMP-activated protein kinase. Trends Biochem. Sci. 1999; 24: 22-5.
26. Balon TW, Jasman AP. Acute exposure to AICAR increases glucose transport in mouse EDL and soleus muscle. Biochem. Biophys. Res. Commun. 2001; 282: 1008-11.
27. Passonneau JV, Lauderdale VR. A comparison of three methods of glycogen measurement in tissues. Anal. Biochem. 1974; 60: 405-12.
28. Harris RC, Hultman E, Nordesjo LO. Glycogen, glycolytic intermediates and high-energy phosphates determined in biopsy samples of musculus quadriceps femoris of man at rest. Methods and variance of values. Scand. J. Clin. Lab. Invest. 1974; 33: 109-20.
29. Lowry OH, Passonneau JV. A Flexible System of Enzymatic Analysis. Academic Press, New York. 1972.
30. Snow RJ, McKenna MJ, Selig SE, Kemp J, Stathis CG, Zhao S. Effect of creatine supplementation on sprint exercise performance and muscle metabolism. J. Appl. Physiol. 1998; 84: 1667-73.
31. Dean DJ, Kurowski T, Kaushik V, Ruderman NB. Nitric oxide synthase (NOS) does not appear to be involved in the AMP-activated protein kinase (AMPK) mediated increase in 3-O-methylglucose transport in isolated extensor digitorem longus (EDL). Diabetes 2001; 50 (Suppl. 2): A222 (Abstract).
32. Derave W, Ai H, Ihlemann J et al. Dissociation of AMP-activated protein kinase activation and glucose transport in contracting slow-twitch muscle. Diabetes 2000; 49: 1281-7.
33. McConell GK, Stepto NK, Chen Z-P et al. Short-term exercise training suppresses increases in human skeletal muscle AMPK activity during prolonged exercise. Diabetes 2002; 51 (Suppl. 2): A253 (Abstract).
34. Chen ZP, Mitchelhill KI, Michell BJ et al. AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett. 1999; 443: 285-9.